Lmr Partners LLP Novavax Inc Call Options Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 07, 2024	SELL	$10.71 - $17.11 $535,500 - $855,500	-50,000 Reduced 59.67%	33,800 $426,000
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $325,982 - $1.76 Million	83,800 New	83,800 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $443,520 - $708,708	-92,400 Reduced 75.49%	30,000 $144,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $833,544 - $1.19 Million	122,400 New	122,400 $886,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.